Zivment-CV 625 is a powerful broad-spectrum antibiotic combination featuring Amoxycillin and Potassium Clavulanate designed to treat a wide variety of bacterial infections. Amoxycillin, a penicillin-type antibiotic, works by stopping the growth of bacteria, while Potassium Clavulanate acts as a beta-lactamase inhibitor that prevents bacteria from destroying the Amoxycillin, thereby enhancing its effectiveness against resistant strains. This synergistic formulation is highly effective for managing infections of the respiratory tract, urinary tract, skin, and soft tissues, ensuring a more comprehensive therapeutic reach. Each film-coated tablet contains 500 mg of Amoxycillin and 125 mg of Clavulanic Acid, providing a robust defense against pathogens that produce beta-lactamase enzymes.
ZIVMENT-CV 625
Composition:
Each film-coated tablet contains 500 mg of Amoxycillin and 125 mg of Clavulanic Acid
Packing:
10 X 10
